POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 mg Daily) in Post Menopausal Women With Parkinson's Disease A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, T ...
Parkinson's Disease
Drug: Premarin ®
The Parkinson Study Group
Wyeth is now a wholly owned subsidiary of Pfizer;Joseph and Rosalyn Newman Foundation